UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Pharmaceuticals shifting from traditional to digital sales marketing: IQVIA
Pharmaceutical firms are increasingly turning to digital channels to carry ...
by Marian Chu
|
2018-07-03 17:44
라인
Platform technologies key to developing new drugs
Major pharmaceutical firms such as Hanmi Pharmaceutical, Green Cross Lab Ce...
by So Jae-hyeon
|
2018-07-03 16:12
라인
MSD Korea fails to submit PMS data, gets Elonva approval canceled
The Ministry of Food and Drug Safety Thursday canceled the approval for MSD...
by Marian Chu
|
2018-07-03 16:11
라인
SillaJen to develop biomarker for JX-970
SillaJen is rolling up its sleeves to develop a biomarker for an investigat...
by So Jae-hyeon
|
2018-07-03 14:19
라인
Ministry approves CJ Healthcare’s CINV treatment
CJ Healthcare said Monday it has received approval from the Ministry of Foo...
by Lee Han-soo
|
2018-07-03 12:47
라인
Alexion Pharma Korea’s aHUS therapy Soliris gains coverage
Alexion Pharma Korea gained reimbursement from the Ministry of Health and W...
by Marian Chu
|
2018-07-02 17:02
라인
Takeda’s diabetes therapy to see 10 generics soon
Ten generics of Takeda Pharmaceutical’s diabetes adjunct therapy Actos met ...
by Marian Chu
|
2018-07-02 17:01
라인
‘Bleeding risk lowest in Eliquis among NOACs for AF patients’
Eliquis (ingredient: apixaban) by Bristol-Myers Squibb Korea and Korea Pfiz...
by Nam Doo-hyun
|
2018-07-02 16:47
라인
SK Bioscience starts business
SK Bioscience CEO Ahn Jae-yong SK Chemicals announced on Sunday that it h...
by Lee Han-soo
|
2018-07-02 15:00
라인
Sanofi Korea presents findings on head-to-head trial on Toujeo vs. Tresiba
Sanofi presented head-to-head trial results for Toujeo Monday. Sanofi’s d...
by Marian Chu
|
2018-06-29 18:01
라인
VUNO unveils SW with excellent function for predicting cardiac arrest
VUNO has released new study results, which show its artificial intelligence...
by Marian Chu
|
2018-06-29 17:29
라인
Eisai’s Aricept dominates dementia treatment market
Eisai’s Aricept has comfortably secured the No. 1 place in the local dement...
by So Jae-hyeon
|
2018-06-29 15:24
라인
BMS Korea wins fight for Eliquis patent
Bristol-Myers Squibb (BMS) Korea said it has won a suit against domestic dr...
by Nam Doo-hyun
|
2018-06-29 14:41
라인
Botulinum toxin makers compete to expand indications
Local developers of botulinum toxins are increasingly competing to expand t...
by So Jae-hyeon
|
2018-06-29 14:07
라인
Korean pharmaceuticals fail to invalidate Invokana patent
A three-year-long trial to invalidate the patent for Janssen’s diabetes dru...
by Marian Chu
|
2018-06-28 17:58
라인
Pfizer’s kidney cancer therapy Inlyta to be reimbursed in July
The Ministry of Health and Welfare announced Wednesday that it would add Pf...
by Lee Hye-seon
|
2018-06-28 17:57
라인
Weight-loss drug Saxenda creates marketing sensation in Korea
Saxenda (ingredient: liraglutide), an injectable drug to treat obesity, is ...
by Lee Hye-seon
|
2018-06-28 16:40
라인
Hugel, Hamni to cooperate in urology market
Hugel, a biopharmaceutical company, announced Thursday that it has entered ...
by Lee Han-soo
|
2018-06-28 16:39
라인
Herbalife Korea publishes results of genetic big data analysis
Herbalife Korea announced Thursday the results of its big data analysis of ...
by Marian Chu
|
2018-06-28 14:52
라인
Hepatitis B reactivation added to Simulect precautions
The government said it has ordered Novartis to add “hepatitis B reactivatio...
by Lee Hye-seon
|
2018-06-28 12:20
-
이전
71
72
73
74
75
76
77
78
79
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top